**Core tip:** Amniotic stem cells were exploited as a cell source alternative to liver transplantation therapy instead of induced pluripotent stem cells. However, they presented with low hepatic function efficiency. We used 3D co-culture and a combination of supportive somatic stem cells to simulate an *in vivo* microenvironment. Our selected subpopulation of adherent amniotic stem cells self-organized *ex vivo* and generated functional organoids. Cell selection methods and bioinformatics may help refine the differentiation protocol.

INTRODUCTION
============

Liver cirrhosis and liver failure are global problems. They are caused by viral infections, alcoholic- or non-alcoholic steatohepatitis, autoimmune hepatitis, metabolic and hereditary diseases, and others\[[@B1]\]. The only curative treatment is liver transplantation. However, there is a worldwide shortage of liver donors. Moreover, liver transplantation is associated with high mortality and morbidity and high-risk patients with comorbidity do not meet the indication criteria\[[@B2],[@B3]\]. Cell transplantation has been proposed as an alternative therapy to whole organ transplantation. Several cells have been investigated as hepatic cell sources. Human donor-derived hepatocyte transplantation was attempted to cure cirrhosis and it did have some therapeutic benefit\[[@B4],[@B5]\]. However, it required many hepatocytes and failed to solve the problem of donor insufficiency.

Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) are known to differentiate into hepatocytes\[[@B6]\]. Although they have a high potential for hepatic differentiation, there are ethical, tumorigenicity, and cost issues associated with them. Previous reports indicated that somatic cells such as fibroblasts were induced to differentiate into hepatocyte-like cells by direct reprogramming\[[@B7],[@B8]\]. In this case, virus-mediated overexpression of lineage-specific transcription factors was needed. Other cell types include mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs), menstrual blood-derived stem cells, and amniotic stem cells (ASCs)\[[@B5],[@B9]\]. Somatic stem cells require only differentiation factors but no gene editing. The latter may cause undesirable and unexpected side effects. Here, we attempted to induce ASCs to differentiate into hepatocytes because they have several beneficial characteristics.

Amniotic epithelial cells (AECs) are easily isolated from amniotic membranes after delivery. This process causes no harm to the donor. Embryologically, the amnion is derived from the epiblast which can differentiate into three germ layers. Even at full term pregnancy, this differentiation potential persists in ASCs which are an immature subpopulation of AECs\[[@B10]\]. AECs also have immune tolerance and are therefore suitable for allogenic transplantation\[[@B11],[@B12]\]. Furthermore, they have certain features, in common with hepatocytes such as the expression of *ALB, AAT*, or *CYP3A4*\[[@B13]\].

Previous studies attempted to differentiate AECs into hepatocyte-like cells in 2D culture\[[@B14],[@B15]\]. However, no differentiation protocol was established. Without systemic and comprehensive analyses in vivo or in vitro, AEC quality could not be verified and it may have been unsatisfactory and inferior to ESCs or iPSCs\[[@B5]\]. Therefore, its functional activity would be insufficient for clinical use when a higher level of hepatic function was required. Moreover, as the general AEC profile had not yet been elucidated, it was difficult to determine which differentiation protocol was appropriate for AECs. Therefore, we endeavored to clarify AEC stemness characteristics, heterogeneity, and general profile by using transcriptomes. We also tried to select an adherent subpopulation to purify ASCs.

A 3D culture system may promote and enhance stem cell differentiation potential in co-culture with endothelial, mesenchymal, and other cells\[[@B16],[@B17]\]. Here, we combined 3D culture conditions and co-culture with other somatic stem cells and supportive stroma cells. We attempted to simulate an *in vivo*-like microenvironment using a selected subpopulation of adherent ASCs for *ex-vivo* self-organization and ultimately obtained functional organoids.

MATERIALS AND METHODS
=====================

Isolation of somatic stem cells
-------------------------------

**AECs:** Human placenta was acquired from the University of Tsukuba Hospital with approval from the institutional review board (IRV code: H27-58). All samples were collected from patients who had provided informed consent. Emergent operation cases were excluded. The amniotic membrane was peeled off the placenta in the operating room immediately after birth. After washing in pre-digestion buffer (Hank's balanced salt solution, HBSS; Wako Pure Chemical Industries Ltd., Osaka, Japan) with 0.02% egtazic acid (EGTA; Wako Pure Chemical Industries Ltd., Osaka, Japan), the membrane was incubated in 0.05% trypsin-EDTA (Thermo Fisher Scientific, Waltham, MA, United States) at 37 °C for 20-30 min. HBSS with 10% fetal bovine serum (FBS; Thermo Fisher Scientific, Waltham, MA, United States) was added and gentle agitation followed to detach the epithelial cells from the membrane. The cells were incubated with 0.05% trypsin-EDTA and washed again to collect the AECs. A 100-µm strainer (Merck EMD, Darmstadt, Germany) was used to remove a clot from the cell suspension and isolate primary AECs. Viability was checked with 0.4% trypan blue dye (Dojindo Laboratories, Kumamoto, Japan) and found to be \> 90%.

**Human umbilical vein endothelial cells (HUVECs):** After the umbilical cords were harvested, the umbilical veins were filled with collagenase buffer (HBSS with 0.24% 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES; Merck EMD, Darmstadt, Germany), 0.005% trypsin inhibitor (Wako Pure Chemical Industries Ltd., Osaka, Japan), and 0.05% collagenase (Worthington Biochemical Corporation, Lakewood, NJ, United States). The veins were incubated at 37 °C for 15 min. The buffer was centrifuged at 450 × g and 4 °C for 5 min to obtain a cell pellet containing HUVECs. This pellet was seeded to a plate using an EGM Bullet Kit (Lonza, Basel, Switzerland). In most cases, the HUVECs grew to confluence within 4 d.

**MSC:** After HUVEC collection, Wharton\'s jelly was minced and seeded to a plate with Dulbecco's modified Eagle's medium and 10% FBS. Attached MSCs were isolated and in most cases, they grew to confluence within 2 wk.

Cell culture
------------

**2D culture:** For the AECs, a custom culture medium was blended and named AEC basal medium (AECBM). The media and protocols are listed in Supplementary Figure 1. Primary AECs were used in most analyses. In the culture experiments, however, AECs were precultured with AECBM for 5-7 d then used for differentiation. In the present study, the multistep hepatic differentiation protocol of Nie et al\[[@B17]\] was applied. In that study, iPSCs were differentiated into hepatocytes. The AEC culture medium was changed step by step within 3 wk.

![Characteristics of human amniotic membrane and amniotic epithelial cells. A: H and E staining of amniotic membrane. Bar, 50 µm; B: AP staining of amniotic membrane. Positive cells are indicated with arrows. Bar, 100 µm. In A and B, the amniotic membrane was rolled before embedding. Therefore, many layers can be seen in one picture; C: Immunofluorescent staining of frozen section of amniotic membrane. Anti-SSEA4 antibody (green), E-cadherin antibody (red), and DAPI were used; D: Same as C. Anti-TRA-1-81 antibody (green), anti-EPCAM antibody (red), and DAPI were used; E: Direct tissue staining of amniotic membrane. Anti-TRA-1-60 antibody (green) and DAPI were used. Bars in C, D, and E represent 100 µm; F: Colonies formed from cultured amniotic epithelial cells (AECs) and observed by phase-contrast microscopy. Bar to left of F represents 200 µm. Bar to right of F represents 500 µm; G: Frequency of colony formation from primary AECs and adherent AECs. Cells which did not attach to the well surface were removed to purify the amniotic stem cells; H: Gene expression of primary AECs, mesenchymal stem cells(MSCs), and induced pluripotent stem cells(iPSCs) detected by qRT-PCR; I: surface markers of primary AECs verified by flow cytometry.](WJSC-11-705-g001){#F1}

Another simple differentiation protocol from AECs to hepatocytes was reported by Maymó et al\[[@B14]\]. In brief, the cells were cultured for 1 wk in Iscove's modified Dulbecco's medium containing epidermal growth factor (EGF) then cultured with EGF and dexamethasone. This method was named the two-step protocol.

**3D culture:** A primary 2D culture was prepared to select a subpopulation of adherent AECs. Unattached cells were removed after 72 h. A 24-well 3D micropattern culture plate (Kuraray, Tokyo, Japan) was used for the next step. After coating the plate with lipidure (NOF Corporation, Tokyo, Japan), the precultured AECs were seeded at a density of 10^6^/well. The AECs formed a sphere within 3-7 d. AECs, HUVECs, and MSCs were used for organoid propagation and they formed spheres within 1 d.

qRT-PCR
-------

The primers used are listed in Table [1](#T1){ref-type="table"}. The TaqMan PCR protocol from Integrated DNA Technologies, Inc. (Coralville, IA, United States) was used. In brief, the RNA was extracted from the cultured cells with Isogen (Nippon Gene, Tokyo, Japan). Then the isolated RNA was converted to cDNA with a Revert Aid RT kit (Thermo Fisher Scientific, Waltham, MA, United States). The cDNA, primers, probes, reference dye, and PrimeTime Gene Expression Master Mix (Integrated DNA Technologies, San Jose, CA, United States) containing hot-start DNA polymerase, dNTPs, enhancers, and stabilizers were combined. A 7500 Real-Time PCR System (Thermo Fisher Scientific, Waltham, MA, United States) ran the PCR.

###### 

List of primers

  **Name**                            **Primer sequence**
  ---------- ------------------------ --------------------------
  *SOX2*     F                        TGCACCGCTACGACGTGA
  R          GGAGCCAAGAGCCATGCC       
  *NANOG*    F                        TGCTGAGATGCCTCACACG
  R          TGCAGAAGTGGGTTGTTTGC     
  *OCT4*     F                        GAAACCCACACTGCAGCAG
  R          GACCCAGCAGCCTCAAAATC     
  *LIN28*    F                        GGATGTCTTTGTGCACCAGAGTA
  R          TGGATTCCAGACCCTTGGCT     
  *ALB*      F                        TGCCTGTTGCCAAAGCTCG
  R          GCTACTGCCCATGCTTTGAAAG   
  *AFP*      F                        GCAAACGATGAAGCAAGAGTTTC
  R          GCAGCATTTCTCCAACAGGC     
  *AAT*      F                        ACTGGAACCTATGATCTGAAGAGC
  R          GCCTTATGCACGGCCTTGG      
  *CYP3A4*   F                        GGATGAAAGAAAGTCGCCTCGA
  R          TCCAGATCGGACAGAGCTTTG    
  *ACTB*     F                        CCTCGCCTTTGCCGATCC
  R          CATGCCGGAGCCGTTGT        

Immunofluorescence analysis
---------------------------

Amnion and organoids were stained with following antibodies: Primary; SSEA4, TRA-1-60, TRA-1-81 (Cell Signaling Technology, Danvers, MA, United States), EPCAM (BD, Franklin Lakes, NJ, United States), E-cadherin (BD, Franklin Lakes, NJ, United States). Frozen sample sections were fixed with 50% acetone (Wako Pure Chemical Industries Ltd., Osaka, Japan) and 50% methanol (Wako Pure Chemical Industries Ltd., Osaka, Japan) for 30 min.

The samples were incubated with primary antibody at 4 °C overnight, washed 3 ×, and incubated with a fluorescence-conjugated secondary antibody for 1 h at 20-25 °C. Before each antibody incubation, blocking was performed with 10% normal goat serum (NGS; Merck EMD, Darmstadt, Germany). In the last step, the samples were mounted with 4',6-diamidino-2-phenylindole (DAPI; Dojindo Laboratories, Kumamoto, Japan) and photographed under an All-in-One Fluorescence Microscope (BZ-X710; Keyence, Osaka, Japan) or a confocal microscope (Leica TCS SP6; Leica Microsystems, Wetzlar, Germany).

For live amnion staining, the amnion was incubated with anti-TRA-1-60 antibody for 30 min at 37 °C and then with Hoechst (Dojindo Laboratories, Kumamoto, Japan) for 15 min at 37 °C. Pictures were obtained with an Inverted System Microscope IX71 (Olympus, Tokyo, Japan).

Flow cytometry
--------------

The following antibodies and DAPI were used: SSEA4-FITC (BioLegend, San Diego, CA, United States), TRA-1-81-PE (Thermo Fisher Scientific, Waltham, MA, United States), TRA-1-60-PE (Thermo Fisher Scientific, Waltham, MA, United States), E-cadherin-Alexa Flour 647 (BD, Franklin Lakes, NJ, United States), and EPCAM-APC (BD, Franklin Lakes, NJ, United States). The cells were incubated with antibody on ice for 30 min then washed twice. The cells were analyzed in FACS Jazz (BD, Franklin Lakes, NJ, United States) and FlowJo v. 7.6.1 (FlowJo LCC, Ashland, CO, United States).

Colony formation assay
----------------------

Primary and adherent AEC subpopulations were compared in a colony formation assay. To collect the adherent AEC subpopulation, a selective primary passage was used. This process was the same as the preculture step for the 3D culture, namely, nonattached cells were removed after 72 h culture. Primary and adherent AECs were seeded in a six-well plate at a density of 3000-20000 cells/well with AECBM. After 6 d of incubation, the numbers of colonies containing \> 20 cells were counted and traced by scanning under an All-in-One Fluorescence Microscope (BZ-X710). The number of colonies was divided by the seeding number to calculate the colony formation frequency.

Whole-transcriptome shotgun sequencing and bioinformatics analysis
------------------------------------------------------------------

Total RNA was extracted from primary AECs and RNA sequencing was performed by Eurofins Genomics K.K. (Tokyo, Japan) who used the Illumina HiSeq 2500 (Illumina, San Diego, CA, United States). Gene expression data for the other cell sources were obtained from the National Center for Biotechnology Information Sequence Read Archive (SRA) database (https://[www.ncbi.nlm.nih.gov/sra](www.ncbi.nlm.nih.gov/sra)). Data sources are listed in Table [2](#T2){ref-type="table"}.

###### 

RNAseq data sources used in the bioinformatics analysis

  **Sample name**   **SRA number**   **Instrument**        **Memo**                                                      **Ref.**
  ----------------- ---------------- --------------------- ------------------------------------------------------------- ------------
  AEC-1             SRR9643783       Illumina HiSeq 2500   Primary AEC                                                   
  AEC-2             SRR9643784       Illumina HiSeq 2500   Primary AEC                                                   
  MSC-1             SRR6431450       Illumina HiSeq 2000                                                                 \[[@B44]\]
  MSC-2             SRR6431451       Illumina HiSeq 2000                                                                 \[[@B44]\]
  hESC-1            SRR4241924       Illumina HiSeq 4000   H9                                                            \[[@B45]\]
  hESC-2            SRR4241926       Illumina HiSeq 4000   H9                                                            \[[@B45]\]
  NiPS-1            SRR7592168       Illumina HiSeq 2500   Normal human iPSC                                             \[[@B46]\]
  NiPS-2            SRR7592169       Illumina HiSeq 2500   Normal human iPSC                                             \[[@B46]\]
  DE-1              SRR771468        Illumina HiSeq 2000   Definitive endoderm induced from H9                           \[[@B47]\]
  DE-2              SRR771469        Illumina HiSeq 2000   Definitive endoderm induced from H9                           \[[@B47]\]
  hiHep-1           SRR5974291       Illumina HiSeq 2000   Umbilical cord fibroblast derived hepatocyte-like like cell   \[[@B8]\]
  hiHep-2           SRR5974292       Illumina HiSeq 2000   Umbilical cord fibroblast derived hepatocyte-like cell        \[[@B8]\]
  iPSCHLC-1         SRR5974295       Illumina HiSeq 2500   iPSC-derived Hepatocyte-like cell                             \[[@B8]\]
  iPSCHLC-2         SRR5974296       Illumina HiSeq 2500   iPSC-derived hepatocyte-like cell                             \[[@B8]\]
  Hepa-1            SRR6176953       Illumina HiSeq 2500   Hepatocyte from clinical sample of adult                      \[[@B48]\]
  Hepa-2            SRR6176948       Illumina HiSeq 2500   Hepatocyte from clinical sample of adult                      \[[@B48]\]
  Hepa-3            SRR5974298       Illumina HiSeq 2000   Primary human hepatocyte 2 d                                  \[[@B8]\]
  Hepa-4            SRR5974299       Illumina HiSeq 2000   Primary human hepatocyte 4 d                                  \[[@B8]\]

RNA Sequencing. All paired-end reads were trimmed and quality-filtered via CLC Genomics Workbench v. 10.1.1 (Qiagen, Hilden, Germany) which was also used to map the filtered reads against the human reference sequence (hg 19). Mapped reads were counted and transcript abundance was measured in TPM (transcripts per kilobase million) units.

Bioinformatics for RNA Sequencing Data. An original read count matrix was normalized with DESeq2 v. 3.5.2 for unified expression level. All normalized log-transformed expression values were ordered according to the median absolute deviation. The top 3500 genes were selected for a heatmap which was generated with the pheatmap package in R.

ICG test
--------

AEC spheres or multiple stem cell-derived organoids were incubated with AECGM and 1 mg/mL indocyanine green (ICG) (Daiichi Sankyo, Tokyo, Japan) for 30 min at 37 °C. They were then observed under bright field with an Inverted System Microscope IX71 to confirm ICG absorption. They were then incubated with ICG-free AECGM for 6 h and checked for ICG elimination.

Statistical analysis
--------------------

GraphPad Prism v. 8.0.1 (GraphPad Software, La Jolla, CA, United States) was used to process all data. A Wilcoxon signed-rank test compared means between pairs of groups. *P* \< 0.05 was considered statistically significant.

RESULTS
=======

Characterization of amnion-derived stem cells
---------------------------------------------

The amnion consisted of monolayer epithelium and mesenchyme (Figure [1A](#F1){ref-type="fig"}). We first examined the stemness characteristics of the amnion. Using an AP staining kit (Muto Pure Chemicals, Tokyo, Japan), we found that a small proportion of the epithelial cells were blue (Figure [1B](#F1){ref-type="fig"}). AP is often used as a multipotency marker. Immunofluorescence analysis of frozen amnion sections (Figures [1C](#F1){ref-type="fig"} and [1D](#F1){ref-type="fig"}) indicated that its epithelium was positive for the stemness markers SSEA4, E-cadherin, and EPCAM. However, other stemness markers such as TRA-1-60 (not shown) and TRA-1-81 were not detected. Previous studies\[[@B18],[@B19]\] reported that a small subpopulation of AEC expresses TRA-1-60 or TRA-1-81. We attempted live staining of fresh amnion and found a low frequency of TRA-1-60-positive cells (Figure [1E](#F1){ref-type="fig"}). We concluded that amniotic epithelium has certain stemness or multipotency markers and only a subpopulation of its cells expresses stemness.

The AEC isolation method yielded 1-6 × 10^7^ AECs with \> 90% viability. We then examined AEC morphology, colony formation capability, and stemness markers. We seeded AECs into a plate and observed them by phase contrast microscopy (Figure [1F](#F1){ref-type="fig"}). Although only a few primary AECs attached to the plate as short, spindle-like cells within 1 d, they proliferated well and formed colonies. After the primary selective passage, the colony formation capacity increased ten-fold relative to that for the heterogenous primary AECs (Figure [1G](#F1){ref-type="fig"}). We also verified the gene expression of stemness markers by qRT-PCR. *OCT4, NANOG, SOX2*, and *LIN28*, which are important iPSC markers, were expressed at very low levels in AECs compared with those in iPSCs but at higher levels than those in MSCs (Figure [1H](#F1){ref-type="fig"}). We also analyzed the stemness surface markers by flow cytometry (Figure [1I](#F1){ref-type="fig"}). E-cadherin and EPCAM expression was highly positive. Certain SSEA4s were highly positive while others were only weakly positive. Only 10% of the TRA-1-81 and TRA-1-60 were positive. Based on the foregoing information, we concluded that amnion and AECs have stemness and amniotic stem cells widely express stemness markers.

Hepatic potentials and profiling by whole-transcriptome shotgun sequencing
--------------------------------------------------------------------------

According to previous reports, AECs can differentiate into hepatocytes\[[@B20],[@B21]\]. Here, we performed comprehensive profiling by whole-transcriptome shotgun sequencing to verify this potential in AECs. We also compared the AEC RNA sequences with those of pluripotent stem cells, hepatocytes or induced hepatocytes, and MSCs. MSCs are also often used as hepatocyte cell sources\[[@B9]\]. First, we normalized the data and checked its repeatability using Pearson's correlation coefficient (Supplementary Figures 2A and 2B). A principal component analysis (PCA) and a general heatmap (Figures [2A](#F2){ref-type="fig"} and [2B](#F2){ref-type="fig"}) indicated that AECs and MSCs differ across the spectrum ranging from pluripotent stem cells to hepatocytes. Even human fibroblast-derived hepatocyte-like cells (hiHep) and iPSC-derived hepatocyte-like cells (iPSCHLCs), which had immature hepatic characteristics\[[@B8]\], did not closely resemble hepatocytes. An unexpected finding was that AECs were like hiHep and iPSCHLCs. We gathered 40 stem cell- and 66 hepatic cell markers to make a heatmap (Figure [2C](#F2){ref-type="fig"}). CD9 and TJP1 were highly expressed in both AECs and ESCs. *IGF2BP2* and *KRT19* were highly expressed in both AECs and the definitive endoderm. The hepatic markers *MET, ABCC2, CYP1A1*, *etc*. were highly expressed in AECs. The markers expressed in AECs are listed in Table [3](#T3){ref-type="table"}. The features common to AEC, pluripotent stem cells, and hepatocytes may help elucidate the differentiation mechanism.

![Characteristics of primary amniotic epithelial cells and other cell sources verified by bioinformatics. A: Principal component analysis of all cell sources used in this assay; B: General heatmap for each cell source; C: Specific heatmap of stemness and hepatic markers. AEC: Amniotic epithelial cell; Hepa: Hepatocyte; hiHep: Human fibroblast-derived hepatocyte-like cell; MSC: Mesenchymal stem cell; DE: Definitive endoderm; hESC: Human embryonic stem cell; iPSCHLC, iPSC-derived hepatocyte-like cell; NiPS: Normal human iPSC.](WJSC-11-705-g002){#F2}

###### 

Stemness (upper)- and hepatic (lower) genes expressed in amniotic epithelial cells.

  **Gene symbol**   **Explanation**                                                                                                                                                                                                                          **Ref.**
  ----------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------
  *CD9*             CD9 belongs to the transmembrane 4 superfamily. It is associated with cell proliferation, motility, and adhesion and regulates hematopoietic differentiation                                                                             \[[@B49]\]
  *TJP1*            Tight junction protein 1 is a determinant of plasma cell proteasome and is associated with EGFR, JAK1, and STAT3. It is regulated by TGF-b and involved with cell motility                                                               \[[@B30],[@B50]\]
  *IGF2BP2*         This member of the insulin--like growth factor 2 mRNA-binding protein family participates in normal embryonic growth and development. It is expressed in the pancreas and associated with type 2 diabetes mellitus                       \[[@B51]\]
  *KRT19*           Keratin 19 is a cytoplasmic intermediate filament protein and belongs to the type 1 keratin family. It is used as a cholangiocyte marker and is not expressed in hepatocytes. It is associated with the progression of several cancers   \[[@B31],[@B32]\]
  *GRB7*            Growth factor receptor-bound protein 7 mediates signal transduction and cell migration. It is associated with the metastasis of several cancers                                                                                          \[[@B52]\]
  *KRT8*            Keratin 8 is a cytoplasmic intermediate filament protein of the type 2 keratin family. It is expressed in single layered epithelial cells. In cancer cells, it is associated with progression in the form of migration and adhesion      \[[@B33]\]
                                                                                                                                                                                                                                                             
  **Gene symbol**   **Explanation**                                                                                                                                                                                                                          **Ref.**
                                                                                                                                                                                                                                                             
  *ApoM*            Apolipoprotein M (apoM) belongs to the lipocalin family. It is expressed in the liver and kidney. Hepatic apoM controls HDL metabolism                                                                                                   \[[@B53],[@B54]\]
  *CPS1*            Carbamoyl phosphate synthase 1 is a mitochondrial enzyme and participates in the first step of the urea cycle in the liver.                                                                                                              \[[@B55]\]
  *SLC51A*          Organic solute transporter subunit alpha is a bile acid transporter in the liver, small intestine, and kidney. It prevents the bile acid reflux                                                                                          \[[@B56]\]
  *IL6ST*           Interleukin 6 signal transducer controls IL-6 and other cytokines such as IL-11, IL-27, oncostatin M, and leukemia inhibitory factor                                                                                                     \[[@B57]\]
  *ACOX1*           Acyl-CoA oxidase 1 is a rate-limiting enzyme in fatty acid β-oxidation                                                                                                                                                                   \[[@B58]\]
  *RXRa*            The nuclear hormone receptor retinoid X receptor belongs to the steroid hormone receptor family. It is a key factor of cholesterol synthesis                                                                                             \[[@B59]\]
  *MET*             MET encodes the hepatocyte growth factor (HGF) receptor and the key factor of hepatic regeneration. It activates epithelial migration and 3D morphogenesis                                                                               \[[@B35],[@B36]\]
  *ABCC2*           ATP binding cassette subfamily C member 2 is expressed in the hepatocytes and is a biliary transporter. It is also related to drug elimination and multidrug resistance in several cancers                                               \[[@B60]\]
  *CYP1A1*          This member of the cytochrome P450 enzyme superfamily participates in fatty acid and steroid metabolism. It is associated with the detoxification of anthropogenic chemicals such as polycyclic aromatic hydrocarbons                    \[[@B61]\]

Hepatic differential induction with a 3D culture system
-------------------------------------------------------

To induce hepatic differentiation, we raised AECs under a hepatic differentiation protocol and a 3D culture system (Figure [3A](#F3){ref-type="fig"}). First, we tested the hepatic differentiation protocol in 2D culture. We attempted a two-step differentiation protocol using AECBM as a negative control. In the 2D culture, the AECs were short-lived. Nearly all the cells were detached from the culture plate within 3 wk. Moreover, gene expression did not markedly increase during the culture period (Supplementary Figure 3).

![Characteristics of amniotic epithelial cell spheres formed on 3D-micropattern plate. A: 3D-micropattern plate used in the present study. Round pits 500 µm in diameter are clustered on the surface. After culture, the amniotic epithelial cells (AECs) formed a sphere; B: Gene expression in the AEC sphere verified by qRT-PCR; C: After reseeding AEC sphere onto 2D culture dish, AEC proliferation was verified by phase-contrast microscopy. Bar, 500 µm.](WJSC-11-705-g003){#F3}

We then tried 3D culture with three protocols including the two-step, multistep, and AECBM. With a 3D culture system in a micropattern plate, the seeded cells readily aggregated into a sphere and remained viable for 3 wk. We then checked hepatic gene expression by qRT-PCR. Relative to the multistep and AECBM protocols, hepatic gene expression in the two-step group protocol was higher (Figure [3B](#F3){ref-type="fig"} and Supplementary Figure 4). *ALB* and *CYP3A4* were upregulated and sustained for 3 wk. Although *AFP* was upregulated in the 2D preculture then downregulated after 7 d, it gradually increased again within the 3-wk differentiation period. *AAT* was also upregulated over 14 d but was downregulated by 21 d. When we seeded the AEC sphere in a culture plate, we observed active AEC proliferation (Figure [3C](#F3){ref-type="fig"}). Based on the preceding data, we concluded that our 3D cultural system maintains AEC viability for \> 3 wk and accelerates hepatic differentiation especially when a two-step protocol is used.

![Organoid morphology and hepatic function. A and C: Frozen sections of amniotic epithelial cell (AEC) sphere and organoid. The AEC sphere was placed in the upper layer and the organoid was placed in the lower layer. H&E staining is used in A, and Periodic acid Schiff staining is used in C; B: Immunofluorescent organoid staining observed under confocal microscopy. Anti-SSEA4 antibody (green) representing AECs; anti-CD90 antibody (red) representing mesenchymal stem cells and DAPI. Bars in A, B, and C, 50 µm; D: ICG tests on AEC sphere and organoid. The AEC sphere was placed in the upper layer and the organoid was placed in the lower layer.](WJSC-11-705-g004){#F4}

Hepatic function enhancement with multicellular organoids
---------------------------------------------------------

We then attempted co-culture by seeding AEC with MSC and HUVEC to form a multicellular sphere organoid. We examined its morphology, cellular distribution, and functional activity. Hematoxylin and eosin (H and E) staining disclosed that the AEC sphere and the organoid were morphologically similar (Figure [4A](#F4){ref-type="fig"}). However, immunofluorescence with CD31, CD90, SSEA4, and DAPI revealed inner-layer CD31-positive HUVECs (data not shown) and CD90-positive MSCs as well as outer-layer SSEA4-positive AECs (Figure [4B](#F4){ref-type="fig"}). This architecture resembles normal tissue disposition. Periodic acid Schiff staining showed glycogen accumulation in the center of the organoid (Figure [4C](#F4){ref-type="fig"}). Both the AEC sphere and the organoid absorbed ICG but only the organoid could excrete it (Figure [4D](#F4){ref-type="fig"}). From the aforementioned results, we concluded that AECs, MSCs, and HUVECs underwent 3D construction in our 3D co-culture system. Moreover, the organoid resembled a liver bud with complex liver function.

DISCUSSION
==========

AEC characteristics and stemness
--------------------------------

AECs proliferate well and express stemness markers\[[@B20]\]. They also readily differentiate into hepatocyte-like cells in the presence of certain growth factors\[[@B14]\]. Miki et al\[[@B20]\] reported that AECs are derived from epiblasts and some of them remain immature then differentiate into three germ layers\[[@B18],[@B20],[@B22]\]. Amnion immunofluorescence disclosed that only a small proportion of AECs are TRA-1-81- and/or TRA-1-60-positive\[[@B19]\]. Here, it was confirmed by flow cytometry that a small primary AEC subpopulation is TRA-1-60- and/or TRA-1-81-positive and the proportions vary among samples. Izumi et al\[[@B18]\] reported that this subpopulation frequency is higher in early-stage than full-term pregnancies. However, all AECs used in the present study were derived from term pregnancies. Moreover, certain AEC lots with comparatively higher proportions of these stem markers had high colony formation frequencies and grew well. For this reason, it is important to select good AEC lots for differentiation.

Previous studies reported that primary AECs could be classified into three different culture layers, namely, floating, attached, or intermediate\[[@B20]\]. In the present study, we found that adherent cells derived from selective passage of primary AECs had a comparatively high colony formation capability. Based on the foregoing information, adherent subpopulations of passaged AECs were used in the 3D culture. Differentiation efficiency could be enhanced by purifying this high-stemness subpopulation of primary AECs.

Hepatic differentiation protocol
--------------------------------

The iPSC-derived organoids have often been considered as models representing organs with highly complex structures and/or functions such as the intestine, lung, neural tissue, *etc*\[[@B23]-[@B25]\]. Cell-to-cell interactions\[[@B26]\] and hypoxic reactions were key factors in differentiation\[[@B27]\]. In the case of hepatic differentiation from iPSCs, mesenchymal and endothelial cells were reported as important factors\[[@B16]\]. However, only 2D culture was used in the attempt to differentiate AECs into hepatocytes\[[@B14],[@B28]\] and the protocol used was not comparable to that applied in the present study.

Therefore, we compared 2D and 3D culture with several differentiation protocols. The 2D culture method was unsuitable for AECs because the cells did not remain viable in it. In 3D culture, AECs retain their viability and morphology for 21 d. A previous report stated for an iPSCs' hepatic differentiation model in a 3D culture system that hypoxia suppresses cell proliferation and induces differentiation\[[@B26],[@B27]\]. In the present study, AEC sphere proliferation was temporarily arrested during 3D culture then resumed after plate seeding. Therefore, a similar mechanism was assumed to occur under our AEC 3D culture conditions.

To date, no hepatic differentiation protocol has been established for AECs. In certain studies, an iPSC-to-hepatocyte differentiation protocol was used\[[@B15],[@B29]\]. However, this stepwise protocol is complex and requires numerous growth factors. Since AECs are not pluripotent stem cells, it is uncertain whether every protocol step would be absolutely necessary. One report mentioned that activin A is not required for hepatic differentiation from AECs\[[@B15]\]. Activin A is required for the transformation of pluripotent stem cells to the definitive endodermal state. In contrast, the AEC-to-hepatocyte differentiation protocol is comparatively simple\[[@B14]\]. Our results indicated that this straightforward differentiation protocol upregulates AEC hepatic genes. Nevertheless, it may still be inadequate and must, therefore, be modified. Despite this deficiency, the co-culture method can nonetheless generate hepatic function from AECs. We concluded that a 3D co-culture system or a hepatic microenvironment is needed for hepatic differentiation from AECs.

Bioinformatics approach
-----------------------

Bioinformatics is a strong tool for the evaluation of cellular differentiation. It is often applied to iPSCs but not to AECs. Our PCA and general heatmap revealed that hiHep\[[@B8]\] and iPSCHLCs\[[@B8]\] remotely resemble mature hepatocytes. In fact, they are regarded as immature hepatocytes. AECs and MSCs are distant from iPSCs, ESCs, and DE but more closely resemble hiHep and iPSCHLCs. Therefore, AECs may be able to differentiate into hepatocytes in only a few steps.

The stemness and hepatic marker heatmaps disclosed certain genes common to all AECs. *TJP1* is associated with EGFR/JAK1/STAT3 signaling\[[@B30]\]. Every two-step, multistep, and AECBM protocol included EGF and seemed reasonable. *KRT8* and *KRT19* are epidermal markers\[[@B31]-[@B33]\] and are also upregulated in AECs. In the hepatic transdifferentiation from fibroblasts, the first step is to transform mesenchymal cells into epidermal cells\[[@B34]\]. In the differentiation of ESC to DE, *KRT8* and *KRT19* are upregulated. Therefore, differentiation of AECs to hepatocytes may require fewer steps than pluripotent stem cell-to-hepatocyte differentiation.

The hepatic marker *MET* was upregulated in AECs. *MET* encodes the human growth factor (HGF) receptor which is important for hepatocyte proliferation or differentiation\[[@B35],[@B36]\]. HGF may already be sensitive in AECs. In addition, *IL6ST* is upregulated in AECs. It transduces the signals of several chemicals containing oncostatin M. HGF and oncostatin M are normally added to iPSCs in the hepatocyte-like cell protocol but not in our two-step protocol\[[@B6]\]. Therefore, we may be able to improve differentiation by adding HGF or oncostatin M to our two-step protocol. Moreover, other markers of hepatic metabolism may also enhance liver function. A detailed list of the stemness and hepatic genes is presented in Table [3](#T3){ref-type="table"} A bioinformatics approach may help elucidate the differentiation mechanism and improve the protocol used for it.

Future prospects
----------------

An iPSC-derived hepatic organoid has already been created and used in basic research *ex vivo*\[[@B17]\]. However, iPSCs are costly, unstable, and tumorigenic\[[@B37],[@B38]\]. In contrast, our organoid is cost-effective, stable, and non-tumorigenic. AEC organoids with hepatic character could be used both in basic *ex vivo* research and *in vivo* experiments.

The next step of our research is to develop and test a human-to-animal transplantation model with AEC-derived hepatic organoids. According to a previous report, terminal differentiation to a functional hepatocyte would be strongly induced in the recipient liver microenvironment\[[@B15]\]. Even in our organoids simulated the microenvironment, the process would not be as perfect as it would be *in vivo*. Therefore, *in vitro* tests of hepatic organoid function may be imperfect. Nevertheless, we must confirm hepatic function after transplantation. The present study demonstrated that the 3D culture condition temporarily suppressed proliferation but did not entirely cause a loss of this capability. Therefore, proliferation could still occur in vivo with the appropriate signal. Human organoids and animal transplantation models are required for pharmaceutical research and investigations into human-specific infectious disease such as hepatitis B and C\[[@B17],[@B39]\].

A future intended application of our hepatic organoid is as an alternative to organ transplantation as a therapy for hepatic failure. More than one induction step from somatic cells to iPSCs is required and quality and safety must be verified\[[@B40],[@B41]\]. On the other hand, AECs are directly isolated from tissues so they are comparatively safe and reliable.

Safety is of paramount importance in the clinical application of organoids. In this respect, AECs are superior to iPSCs. The safest transplantation model is a private placental and cord blood cell bank. Preserved blood cells can be used as a replacement therapy for hematopoietic disease and the regenerative treatment of congenital heart diseases and other developmental disorders\[[@B42],[@B43]\]. Amnion and umbilical cords also have the same genetic profile as the baby. Therefore, private AEC, MSC, and HUVEC cell banks could be ideal sources of therapeutic materials for infants with developmental conditions.

In conclusion, we selected adherent AECs in which ASCs were purified as a cell source for differentiation into hepatocytes. The 3D- and co-culture systems with MSCs and HUVECs generated multicellular organoids with hepatic function. A bioinformatics approach and cell selection strategy would be useful for further improvement of the protocol and its hepatic function.

ARTICLE HIGHLIGHTS
==================

Research background
-------------------

Cell transplantation is a promising method to solve the problem of organ donor deficiency. Recently, amniotic epithelial cells (AECs) have been studied as a somatic stem cell source for regenerative medicine. It has been reported that AECs possess hepatic differentiation capability and they are more cost-effective and non-tumorigenic compared to other cell types. Therefore, AECs could provide a new cell source for cell transplantation in the future, particularly for liver diseases.

Research motivation
-------------------

However, the general profile for AECs has not been comprehensively analyzed and hepatic differentiation protocol for AECs has also not been established. Therefore, by clarifying the comprehensive characteristics of AECs and refining the hepatic differentiation protocol, we could use it effectively as a transplantation cell source in the future.

Research objectives
-------------------

This study aimed to elucidate the comprehensive characteristics of human AECs, and to establish a novel hepatic differentiation protocol. Additionally, 3D multicellular culture condition and purification of stem cells obtained from AECs were studied, with an intention to improve their differentiation capability.

Research methods
----------------

All examined AECs, mesenchymal stem cells (MSCs), and human umbilical vein endothelial cells (HUVECs) were isolated from the placentae and umbilical cords after cesarean section. Stemness characteristics and heterogeneity of amnion and primary AECs were analyzed by immunofluorescence and AP staining, and flow cytometry. In addition, AEC transcriptomes were analyzed and compared with those for other cell sources based on bioinformatics. An adherent AEC subpopulation was selected from primary isolated AECs and their amniotic stem cell (ASC) purification quality was evaluated based on a colony formation assay. Hepatic differentiation capacities of AECs which were cultured in varying 2D or 3D conditions were compared according to their relative gene expression. Finally, ASCs, MSCs and HUVECs were co-cultured in a 3D system to generate hepatic organoids, and the organoid structure and hepatic function were compared with those of 3D AEC spheres using immunofluorescence imaging, Periodic acid Schiff staining, and an indocyanine green (ICG) test.

Research results
----------------

AECs expressed stemness markers such as EPCAM, SSEA4, and E-cadherin, whereas only limited cells in the AEC subpopulation were AP-positive, or expressed TRA-1-60 and TRA-1-81 stemness marker in the flow cytometry. The colony formation assay revealed that primary AECs could form colonies and the frequency was enhanced ten-fold in the adherent subpopulation. According to bioinformatics analysis of RNA sequencing, the primary AEC gene expression was different from those of pluripotent stem cells and hepatocytes; however, some overlapped genes were detected. Compared with the 2D system, AECs could retain their viability for a longer time in 3D culture conditions and the hepatic gene expressions were comparatively elevated using a two-step differentiation protocol. Furthermore, organoids derived from 3D multicellular culture condition using ASCs, MSCs and HUVECs, showed a 3D hepatic structure with polarity, hepatic-like glycogen storage, and ICG absorption/elimination.

Research conclusions
--------------------

Human AECs are heterogeneous and certain subpopulations exhibit high stemness. AEC transcriptome analysis suggests some advantages and factors related to hepatic differentiation. 3D multicellular culture conditions improve the differentiation of ASCs into functional hepatic organoids.

Research perspectives
---------------------

The results of this comprehensive analysis indicate that AECs have high hepatic differentiation capability which should be optimized. By optimizing the selected high stemness subpopulations of AECs and using a 3D co-culture system, AEC-derived hepatic organoid can be used for performing transplantation experiments to evaluate its *in vivo* function.

ACKNOWLEDGEMENTS
================

We thank Chen Liang, Yoshio Shimizu, Roxanne Sabrina Ramirez, Dan Song, Yoshiaki Uchida and Rui Zhao for their kind support in isolating the human placental tissue specimens.

Institutional review board statement: All specimens and cells from the patients were obtained after their informed consent and ethical permission was obtained for participation in the study.

Conflict-of-interest statement: The authors report no relevant conflicts of interest.

Data sharing statement: Transcriptome datasets of primary amniotic epithelial cells from the Sequence Read Archive (SRA) of the NCBI are available in the website. SRA number is listed in Table 2. Participants gave informed consent for publication.

Manuscript source: Invited manuscript

Peer-review started: February 27, 2019

Article in press: August 27, 2019

Specialty type: Cell and tissue engineering

Country of origin: Japan

Peer-review report classification

Grade A (Excellent): 0

Grade B (Very good): B, B, B

Grade C (Good): 0

Grade D (Fair): 0

Grade E (Poor): 0

P-Reviewer: Li W, Ku SY, Vagholkar KR S-Editor: Dou Y L-Editor: A E-Editor: Zhou BX

[^1]: Author contributions: Furuya K, Sako D, Iwasaki K, Ge JY, Liu LP and Furuta T performed the experiments; Furuya K, Sako D and Iwasaki K analyzed the data; Zheng DX performed bioinformatics; Akimoto K, Yagi H, Hamada H, Isoda H supplied experimental materials and resources; Ohkohchi N and Zheng YW conceived the study; Furuya K drafted the manuscript; Zheng YW and Oda T contributed to discuss and review the final manuscript; all the authors approved the final manuscript; Furuya K, Zheng YW and Sako D contributed equally to this work.

    Supported by National Natural Science Foundation of China, No. 81770621; Ministry of Education, Culture, Sports, Science, and Technology of Japan, KAKENHI, No. 16K15604, No. 18H02866; Japan Science and Technology Agency-Japan International Cooperation Agency\'s (JST-JICA) Science and Technology Research Partnership for Sustainable Development (SATREPS) Project.

    Corresponding author: Yun-Wen Zheng, PhD, Associate Professor, Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, University of Tsukuba Faculty of Medicine, Tennodai 1-1-1, Tsukuba, Ibaraki 305-8575, Japan. <ywzheng@md.tsukuba.ac.jp>

    Telephone: +81-29-8533221 Fax: +81-29-8533222
